Donor Egg IVF

SECTION ONE: HISTORICAL ASPECTS.


1. Gametes and Embryo Donation: An Evolving Medical Contribution to Human Procreation


SECTION TWO: INDICATIONS.


2. Can we Define the Indications for Oocyte Donation?


3. Treatment of Ovarian Failure.


4. Is Donor Egg IVF a Rational Treatment for Genetic Disorders?


5. Reversing the Natural Decline in Human Fertility with Oocyte Donation to Women of Advanced Reproductive Age


SECTION THREE: FACTORS DEFINING SUCCESS.


6. Do Recipient Age and Infertility Diagnosis Affect Pregnancy and Implantation Rates in a Donor Egg IVF Program?


7. Donor Age is Paramount to Success in Oocyte Donation


8. Importance of Transfer and Uterine Factors in a Donor Egg IVF Program.


9. Do Hydrosalpinges Adversely Affect Implantation in Donor Oocyte Cycles?


10. The Effect of Prior Gravidity on the Outcomes of Egg Donation


11. Factors that Determine Discordant Outcomes from Shared Oocytes


12. Blastocyst Culture and Transfer in Oocyte Donation


13. Endometriosis and Oocyte Donation


14. The Best Donor.


15. Clinical Factors Interfering with Endometrial Receptivity.SECTION FOUR: OOCYTE SHARING PROGRAMS.


16. The Shared Donor Oocyte Program: Advantages and Insights.(Egg Recipients Sharing Oocytes from Single Donor).


17. Egg Recipients Sharing Oocytes from Patients Undergoing IVF


18. Does Egg Sharing Compromise the Chances of Donors or Recipients Achieving a Livebirth?


SECTION FIVE: FINANCIAL CONSIDERATIONS.


19. Social and Financial Aspects of Egg-sharing versus Professional Egg Donation


in a Donor Egg IVF Program


20. Eggs for Sale: How Much is Too Much?


21. Subsidized IVF: Egg-sharing as a Source of Donor Eggs


SECTION SIX: DONOR SCREENING.


22. Oocyte Donor Screening: The Selection Process and Cost Analysis.


23. Genetic Screening of Prospective Oocyte Donors


24. Should Donor Egg IVF Programs Accept PCOS Women as Donors?.SECTION SEVEN: POTENTIAL DONORS.


25. Family Members as Gamete Donors and Surrogates


26. Sisters of Women with Premature Ovarian Failure may not be Ideal Ovum Donors


27. Should Nonpatient Volunteers Donate Eggs?


SECTION EIGHT: ASSESSING ENDOMETRIAL RECEPTIVITY.


28. Endometrial Receptivity in Oocyte Donation Cycles


29. Color and Power Doppler for Assessing Endometrial Receptivity


30. Endometrial TB-PCR: Transcription-mediated Amplification or Histopathology.for Endometrial Evaluation in Donor Egg IVF?


SECTION NINE: ENDOMETRIAL PREPARATION.


31. Preparation of the Endometrium for Egg Donation


32. Long Estradiol Replacement in an Oocyte Donation Program.


33. Vaginal Progesterone Gel Preparation in a Donor Oocyte Program


SECTION TEN: STIMULATION PROTOCOLS FOR OOCYTE DONORS.


34. Role of GnRH Analog Depot Preparations in Donor Egg IVF


35. Long Protocol is the Gold Standard for Ovarian Stimulation in Egg Donors.


36. Timing of Placental Competence in Ovum Donation


SECTION ELEVEN: ULTRASOUND.


37. Role of TVS in Assessing Endometrial and Ovarian Morphology in a Donor Egg IVF Program. Imaging Aspects: A Perspective


38. Upper Genital Tract Screening with Hysterosonography in Patients Receiving Donated Oocytes


SECTION TWELVE: SURROGACY.


39. Surrogacy: Ethical, Psychological and Legal Implications.


40. Gestational Surrogacy.SECTION THIRTEEN: ENDOSCOPY.


41. Role of Hysteroscopy in a Donor Egg IVF Program


SECTION FOURTEEN: COUNSELING


42. Counseling Recipients in a Donor Egg IVF Program


43. Potential Psychological Attachments Formed by Egg Donors Involved in Fertility Technology


SECTION FIFTEEN: ETHICS AND RELIGION.


44. Ethical and Religious Considerations in Third Party Reproduction


SECTION SIXTEEN: OBSTETRICS AND PERINATAL OUTCOMES


45. Factors Influencing the Obstetric and Perinatal Outcomes after Oocyte Donation


46. Pregnancy Results and Obstetric Outcomes in Patients 45 years and Older


SECTION SEVENTEEN: LONG-TERM FOLLOW-UP.


47. Health and Development of Donor Egg IVF Children Compared to IVF Children


SECTION EIGHTEEN: LEGISLATION AND GUIDELINES.


48. Donor Egg IVF: Its Regulation in India


49. Egg-sharing and Policy Making


50. Oocyte Donation: The Legislative Framework in Western Europe


SECTION NINETEEN: WHAT’S NEW?.


51. Oocyte Donation to Human Immunodeficiency Virus-1 Serodiscordant Couples


52. Turner’s Syndrome and Oocyte Donation


53. Cross Border or Reproductive Tourism with Special Emphasis on Donor Oocytes.SECTION TWENTY: EPILOGUE.


54. The Internet and Donor Egg IVF


55. Egg Donor: Once Upon a Time—What Will You Tell Them?.


56. Risks of Oocyte Donation


Index